Presented by Dylan Powells, Professor in Public Health & Innovation, University of Stirling

1. Translating digital biomarkers from bench to bedside

2. Standardisation of digital biomarkers in clinical development

• Explore the role of liquid biopsy in tailoring precision medicine approaches for individual cancer patients
• Overcoming current challenges and limitations associated with biopsy techniques
• Exploring tumor heterogeneity

• Therapeutic applications in personalised treatment
• Persisting challenges in utilising AI/ML in Multi-Omics
• Updates on current landscape
• Integrating ML/ AI in Single Cell Analysis
• Analysis of multiple omics-types

Presented by Katrina Campbell, Professor in Food Security and Diagnostics, Queen's University Belfast

 •Biomarker specificity
• Regulatory hurdles
• Patient engagement

• Inferring gene expression from different sequencing datasets
• Normalizing data at the same level for integration
• Combining spatial & sequencing based data

• Current utilisation of single cell analysis: target identification, target validation, bulk data merging
• Characterisation of phenotypic screening assays
• Analysis of perturbational single cell data

• IVDR regulations